Browse Indicators

Indicator title
Percentage of health facilities with systems and items for provision of antiretroviral therapy services
Percentage of newly registered TB patients who are HIV positive
Higher risk sex in the last year
Percentage of health facilities that provide HIV testing and counselling services
Women referred to FP services from ANC services offering the minimum package to prevent HIV in infants and young children
CURRENT: Percent of adults and children with advanced HIV infection receiving antiretroviral therapy (ART)
(TB_PREV) Proportion of ART patients who completed a standard course of TB preventive therapy within the semiannual reporting period
Capacity to provide basic counselling and testing and to manage clinical services for HIV/AIDS
Number of adults newly enrolled in HIV care (pre-ART or ART) during the reporting period
Districts with VCT services
Percentage of patients in opioid substitution therapy (OST) receiving recommended maintenance dose >60mg of methadone or 12mg of buprenorphine
(DIAGNOSED_NAT) The percentage of adults and children living with HIV who know their status (have been diagnosed)
Higher-risk sex among young women and men
Number of people on opioid substitution therapy (OST)
Proportion of HIV-positive TB patients who receive CPT
HIV Testing in Most-at-risk Populations
Institutionalizing youth-friendly health services
National TB policy addresses links between TB and HIV
Condoms available for distribution nation-wide
Number of the targeted population reached with individual and/or small group level HIV prevention interventions that are based on evidence and/or meet the minimum standards required
Per Capita Household Expenditures in HIV-affected Households
HIV prevalence in sub-populations with high-risk behaviour
External Economic Support to the poorest households
(LAB_PTCQI) Number of PEPFAR-supported laboratory-based testing and/or Point-of-Care Testing (POCT) sites engaged in continuous quality Improvement (CQI) and proficiency testing (PT) activities.
Percentage of infants born to HIV-infected women who received an HIV test within 12 months [disaggregated by type/timing of testing (virological testing within 2 months, virological testing between 2 and 12 months or antibody testing between 9 and 12 mont